These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12234981)

  • 1. 9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats.
    Christov KT; Moon RC; Lantvit DD; Boone CW; Steele VE; Lubet RA; Kelloff GJ; Pezzuto JM
    Cancer Res; 2002 Sep; 62(18):5178-82. PubMed ID: 12234981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.
    Christov KT; Moon RC; Lantvit DD; Boone CW; Kelloff GJ; Steele VE; Lubet RA; Pezzuto JM
    Eur J Cancer; 2004 Jun; 40(9):1404-11. PubMed ID: 15177500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats.
    McCormick DL; Rao KV; Dooley L; Steele VE; Lubet RA; Kelloff GJ; Bosland MC
    Cancer Res; 1998 Aug; 58(15):3282-8. PubMed ID: 9699656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of sodium selenite on carcinogenesis of the prostate and other organs induced by methylnitrosourea and testosterone in rats].
    Bespalov VG; Panchenko AV; Murazov IaG; Chepik OF
    Vopr Onkol; 2011; 57(4):486-92. PubMed ID: 22191239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide.
    Pollard M; Luckert PH; Sporn MB
    Cancer Res; 1991 Jul; 51(13):3610-1. PubMed ID: 1829024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N; Sausville EA; Breitman TR
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats.
    Lam HM; Ho SM; Chen J; Medvedovic M; Tam NN
    Endocrinology; 2016 Jan; 157(1):207-19. PubMed ID: 26496021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive effects of zinc on prostate carcinogenesis induced by N-methyl-N-nitrosourea and testosterone in adult male Sprague-Dawley rats.
    Banudevi S; Elumalai P; Arunkumar R; Senthilkumar K; Gunadharini DN; Sharmila G; Arunakaran J
    J Cancer Res Clin Oncol; 2011 Apr; 137(4):677-86. PubMed ID: 20552224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
    Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
    Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer.
    Bosland MC
    Eur Urol; 1999; 35(5-6):459-63. PubMed ID: 10325505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Santinelli A; Mazzucchelli R
    Panminerva Med; 2002 Sep; 44(3):213-20. PubMed ID: 12094135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).
    Webber MM; Bello-DeOcampo D; Quader S; Deocampo ND; Metcalfe WS; Sharp RM
    Clin Exp Metastasis; 1999 May; 17(3):255-63. PubMed ID: 10432011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
    Slawin K; Kadmon D; Park SH; Scardino PT; Anzano M; Sporn MB; Thompson TC
    Cancer Res; 1993 Oct; 53(19):4461-5. PubMed ID: 8402613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat.
    McCormick DL; Rao KV
    Eur Urol; 1999; 35(5-6):464-7. PubMed ID: 10325506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of prostatic intraepithelial neoplasia after effective chemoprevention of microscopic prostate cancer with antiandrogen in a rat model.
    Yamauchi A; Kawai K; Tsukamoto S; Ideyama Y; Shirai T; Akaza H
    J Urol; 2006 Jan; 175(1):348-52. PubMed ID: 16406940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer.
    Tokar EJ; Ancrile BB; Ablin RJ; Webber MM
    J Exp Ther Oncol; 2006; 5(4):323-33. PubMed ID: 17024972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
    Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.